Regulation

A new Health and Human Services rule requiring pharmaceutical companies to disclose list prices for medications in commercial advertisements is unlikely to boost price transparency for consumers. In fact, it may create even more confusion.

If lawmakers want to cut drug spending without leaving patients in the lurch, they’d be wise to foster more competition in the drug marketplace. Price controls are more about limiting access than price.

Eight states are asking a court to strike an Obamacare rule they say violates their authority to protect the judgment and conscience rights of medical professionals.

Conservatives say they hate crony capitalism, but a bill that makes it illegal for a new competitor providing a legal product or service to enter a market takes crony capitalism to a whole new level.

Some conservative Texas lawmakers this legislative session are presenting us with not one but two examples of confusing business protection with free-market support. This is unfortunate, but it may provide an object lesson in the difference between being pro-market and pro-business.

In this letter to Congress, IPI joins with other free market organizations voicing opposition to a new payroll tax and new paid leave entitlement program. 

The Trump administration is trying to strike a blow for rational and honest government, so you know it’s getting a lot of pushback.

In light of the significant transformations in the children’s video programming marketplace in the decades since the Commission adopted many of the KidVid rules, we believe firmly that this is an area ripe for reform and deregulation.